e

eGenesis, Inc.

103 employees

EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Genome Engineering
Genetics
Medical
Biopharma
Life Science

Date founded

2015

Funding rounds raised

Total raised

$125M

from 25 investors over 25 rounds

e

eGenesis, Inc. raised $125M on March 2, 2021

Investors: Polaris Partners, Irving Investors, Samsara BioCapital, Wellington Partners, Monashee Investment Management LLC, K G Khosla compressors, LifeSci Venture Partners, Osage University Partners (OUP) and Leaps by Bayer

e

eGenesis, Inc. raised $100M on November 7, 2019

Investors: 301 Ventures, K G Khosla compressors, ARCH Venture Partners, Alta Partners, Biomatics Capital, Wellington Partners and Fresenius Medical Care

e

eGenesis, Inc. raised $38M on March 16, 2017

Investors: K G Khosla compressors, JDRF T1D Fund, Uprising, Berggruen Holdings, Biomatics Capital, E Squared Capital Management, LLC, Heritage Physician Networks, ARCH Venture Partners and Alta Partners

FAQ